Logo image of CSLR

COMPLETE SOLARIA INC (CSLR) Stock Fundamental Analysis

NASDAQ:CSLR - Nasdaq - US20460L1044 - Common Stock - Currency: USD

1.8  +0.02 (+1.12%)

After market: 1.85 +0.05 (+2.78%)

Fundamental Rating

1

Overall CSLR gets a fundamental rating of 1 out of 10. We evaluated CSLR against 93 industry peers in the Electrical Equipment industry. CSLR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CSLR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CSLR has reported negative net income.
CSLR had a negative operating cash flow in the past year.
CSLR Yearly Net Income VS EBIT VS OCF VS FCFCSLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -778.67%, CSLR is doing worse than 96.74% of the companies in the same industry.
Industry RankSector Rank
ROA -778.67%
ROE N/A
ROIC N/A
ROA(3y)-188.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSLR Yearly ROA, ROE, ROICCSLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

CSLR has a Gross Margin of 17.24%. This is comparable to the rest of the industry: CSLR outperforms 45.65% of its industry peers.
CSLR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSLR Yearly Profit, Operating, Gross MarginsCSLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

CSLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSLR has more shares outstanding than it did 1 year ago.
CSLR has a worse debt/assets ratio than last year.
CSLR Yearly Shares OutstandingCSLR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
CSLR Yearly Total Debt VS Total AssetsCSLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -21.09, we must say that CSLR is in the distress zone and has some risk of bankruptcy.
CSLR has a Altman-Z score of -21.09. This is amonst the worse of the industry: CSLR underperforms 90.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.09
ROIC/WACCN/A
WACC9.98%
CSLR Yearly LT Debt VS Equity VS FCFCSLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

CSLR has a Current Ratio of 0.21. This is a bad value and indicates that CSLR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.21, CSLR is doing worse than 91.30% of the companies in the same industry.
CSLR has a Quick Ratio of 0.21. This is a bad value and indicates that CSLR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.19, CSLR is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.19
CSLR Yearly Current Assets VS Current LiabilitesCSLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CSLR have decreased strongly by -686.25% in the last year.
CSLR shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.50%.
EPS 1Y (TTM)-686.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.9%
Revenue 1Y (TTM)41.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.38%

3.2 Future

The Earnings Per Share is expected to grow by 24.76% on average over the next years. This is a very strong growth
CSLR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 65.04% yearly.
EPS Next Y46.06%
EPS Next 2Y30.73%
EPS Next 3Y27.96%
EPS Next 5Y24.76%
Revenue Next Year-32.57%
Revenue Next 2Y46.97%
Revenue Next 3Y73.65%
Revenue Next 5Y65.04%

3.3 Evolution

CSLR Yearly Revenue VS EstimatesCSLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CSLR Yearly EPS VS EstimatesCSLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSLR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSLR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSLR Price Earnings VS Forward Price EarningsCSLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSLR Per share dataCSLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

CSLR's earnings are expected to grow with 27.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.73%
EPS Next 3Y27.96%

More info and screens

0

5. Dividend

5.1 Amount

CSLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMPLETE SOLARIA INC

NASDAQ:CSLR (2/4/2025, 8:00:00 PM)

After market: 1.85 +0.05 (+2.78%)

1.8

+0.02 (+1.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners15.83%
Inst Owner Change0.77%
Ins Owners26.76%
Ins Owner Change0%
Market Cap132.79M
Analysts85
Price Target4.59 (155%)
Short Float %3.22%
Short Ratio3.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-240.66%
Min EPS beat(2)-363.46%
Max EPS beat(2)-117.86%
EPS beat(4)0
Avg EPS beat(4)-449.39%
Min EPS beat(4)-725.3%
Max EPS beat(4)-117.86%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-55.42%
Min Revenue beat(2)-58.06%
Max Revenue beat(2)-52.79%
Revenue beat(4)0
Avg Revenue beat(4)-32.81%
Min Revenue beat(4)-58.06%
Max Revenue beat(4)-9.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.15%
EPS NY rev (3m)-56.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)56.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.22
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.99
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.81
BVpS-1.25
TBVpS-1.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -778.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.24%
FCFM N/A
ROA(3y)-188.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -449.51%
Cap/Sales 3.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.19
Altman-Z -21.09
F-Score3
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-686.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.9%
EPS Next Y46.06%
EPS Next 2Y30.73%
EPS Next 3Y27.96%
EPS Next 5Y24.76%
Revenue 1Y (TTM)41.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.38%
Revenue Next Year-32.57%
Revenue Next 2Y46.97%
Revenue Next 3Y73.65%
Revenue Next 5Y65.04%
EBIT growth 1Y-51.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4137.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3999.72%
OCF growth 3YN/A
OCF growth 5YN/A